In this study, the CRISPR/Cas-9 mediated the knockout of LRRC56 gene in C57BL/6JGpt mice, which exhibited severe hydrocephalus, situs inversus, male infertility, and a host of morphological and metabolic disorders. The gene discussed is LRRC56; the disease is metabolic disease.